Impact of heart valve decellularization on 3-D ultrastructure, immunogenicity and thrombogenicity

Biomaterials

Volumn 31, Issue 9, 2010, Pages 2549-2554

  Zhou, Jianye ^a,b   Fritze, Olaf ^a   Schleicher, Martina ^a   Wendel, Hans Peter ^a   Schenke Layland, Katja ^c   Harasztosi, Csaba ^a   Hu, Shengshou ^b   Stock, Ulrich A ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b FUWAI HOSPITAL   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biocompatibility; Heart valve; Immune response; Thrombogenicity laser scanning; Ultrastructure

Indexed keywords

HEART VALVES; IMMUNE RESPONSE; LASER SCANNING; THROMBOGENICITY; ULTRASTRUCTURE;

BIOCOMPATIBILITY; ENZYME ACTIVITY; HEART; HISTOLOGY; IMMUNOLOGY; LASER APPLICATIONS; SCANNING; SODIUM; THREE DIMENSIONAL; TISSUE; TISSUE ENGINEERING; VALVES (MECHANICAL);

ELECTRIC DISCHARGE MACHINING;

DEOXYCHOLATE SODIUM; DETERGENT; DODECYL SULFATE SODIUM; EDETIC ACID; NUCLEASE; TRYPSIN;

ANIMAL TISSUE; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DECELLULARIZATION; EXTRACELLULAR MATRIX; HEART VALVE; HISTOLOGY; IMMUNE RESPONSE; IMMUNOGENICITY; LASER MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; SWINE; THROMBOGENICITY;

ANIMALS; CATTLE; ERYTHROCYTE COUNT; HEART VALVES; HUMANS; LEUKOCYTE COUNT; MICROSCOPY, CONFOCAL; PHOTONS; PLATELET COUNT; PULMONARY VALVE; SUS SCROFA; THROMBIN;

SUS;

EID: 74749093502     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.11.088     Document Type: Article

References (21)

1. Schenke-Layland K., Vasilevski O., Opitz F., König K., Riemann I., Halbhuber K.J., et al. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J Struct Biol 143 (2003) 201-208
2. Dohmen P.M., Lembcke A., Hotz H., Kivelitz D., and Konertz W.F. Ross operation with a tissue-engineered heart valve. Ann Thorac Surg 74 (2002) 1438-1442
3. Tudorache I., Cebotari S., Sturz G., Kirsch L., Hurschler C., Hilfiker A., et al. Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves. J Heart Valve Dis 16 (2007) 567-573
4. Schenke-Layland K., Riemann I., Opitz F., König K., Halbhuber K.J., and Stock U.A. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. Matrix Biol 23 (2004) 113-125
5. Kasimir M.T., Rieder E., Seebacher G., Silberhumer G., Wolner E., Weigel G., et al. Comparison of different decellularization procedures of porcine heart valves. Int J Artif Organs 26 (2003) 421-427
6. Schenke-Layland K., Riemann I., Damour O., Stock U.A., and König K. Two-photon microscopes and in vivo multiphoton tomographs - powerful diagnostic tools for tissue engineering and drug delivery. Adv Drug Deliv Rev 58 (2006) 878-896
7. Fritze O, Schleicher M, Koenig K, Schenke-Layland K, Stock U, Harasztosi C. Facilitated Non-Invasive Visualization of Collagen and Elastin in Blood Vessels. Tissue Eng Part C Methods 2009 Oct 5 [Epub ahead of press].
8. Konig K., and Riemann I. High-resolution multiphoton tomography of human skin with subcellular spatial resolution and picosecond time resolution. J Biomed Opt 8 (2003) 432-439
9. Tepe G., Schmehl J., Wendel H.P., Schaffner S., Heller S., Gianotti M., et al. Reduced thrombogenicity of nitinol stents - in vitro evaluation of different surface modifications and coatings. Biomaterials 27 (2006) 643-650
10. Prieto J.M., Recio M.C., Giner R.M., Máñez S., Giner-Larza E.M., and Ríos J.L. Influence of traditional Chinese anti-inflammatory medicinal plants on leukocyte and platelet functions. J Pharm Pharmacol 55 (2003) 1275-1282
11. Tylman M., Bengtson J.P., and Bengtsson A. Activation of the complement system by different autologous transfusion devices: an in vitro study. Transfusion 43 (2003) 395-399
12. Skogby M., Friberg L.G., Adrian K., and Mellgren K. Pharmacological inhibition of plasma coagulation and platelet activation during experimental long-term perfusion. Scand Cardiovasc J 37 (2003) 222-228
13. Hietala E.M., Maasilta P., Välimaa T., Harjula A.L., Törmälä P., Salminen U.S., et al. Platelet responses and coagulation activation on polylactide and heparin-poly -caprolactone-l-lactide-coated polylactide stent struts. J Biomed Mater Res A 67 (2003) 785-791
14. Cebotari S., Lichtenberg A., Tudorache I., Hilfiker A., Mertsching H., Leyh R., et al. Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 114 (2006) I-132-I-137
15. Dohmen P.M., Lembcke A., Holinski S., Kivelitz D., Braun J.P., Pruss A., et al. Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the ross procedure. Ann Thorac Surg 84 (2007) 729-736
16. Oswal D., Korossis S., Mirsadraee S., Wilcox H., Watterson K., Fisher J., et al. Biomechanical characterization of decellularized and cross-linked bovine pericardium. J Heart Valve Dis 16 (2007) 165-174
17. Kasimir M.T., Weigel G., Sharma J., Rieder E., Seebacher G., Wolner E., et al. The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation. Thromb Haemost 94 (2005) 562-567
18. Konertz W., Dohmen P.M., Liu J., Beholz S., Dushe S., Posner S., et al. Hemodynamic characteristics of the Matrix P decellularized xenograft for pulmonary valve replacement during the Ross operation. J Heart Valve Dis 14 (2005) 78-81
19. Yamaguchi Y., Matsumura F., Liang J., Okabe K., Ohshiro H., Ishihara K., et al. Neutrophil elastase and oxygen radicals enhance monocyte chemoattractant protein- expression after ischemia/reperfusion in rat liver. Transplantation 68 (1999) 1459-1468
20. Simon P., Kasimir M.T., Seebacher G., Weigel G., Ullrich R., Salzer-Muhar U., et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 23 (2003) 1002-1006
21. Bastian F., Stelzmüller M.E., Kratochwill K., Kasimir M.T., Simon P., and Weigel G. IgG deposition and activation of the classical complement pathway involvement in the activation of human granulocytes by decellularized porcine heart valve tissue. Biomaterials 29 (2008) 1824-1832